Related Articles
Evidence-based study on antithrombotic therapy in patients at risk of a stroke with paroxysmal atrial fibrillation
Influence of CYP2C19 genotype on antiplatelet treatment outcomes after percutaneous coronary intervention in patients with coronary heart disease
Clinical outcomes of various continued antiplatelet therapies in patients who were administered DAPT following the implantation of drug-eluting stents and developed gastrointestinal hemorrhage
Analysis of thrombelastogram-guided medication in patients with coronary heart disease after percutaneous coronary intervention
Use of dabigatran vs. warfarin with low‑molecular‑weight heparin bridging in catheter ablation for atrial fibrillation patients with a low CHADS2 score